1 Report Overview 1.1 Research Scope 1.2 Market Segment by Type 1.2.1 Global Organ Transplant Immunosuppressant Drugs Market Size Growth Rate by Type (2017 VS 2021 VS 2028) 1.2.2 Antibodies 1.2.3 Antiproliferative Agents 1.2.4 Calcineurin Inhibitors 1.2.5 mTOR Inhibitors 1.2.6 Steroids 1.3 Market Segment by Application 1.3.1 Global Organ Transplant Immunosuppressant Drugs Market Share by Application (2017 VS 2021 VS 2028) 1.3.2 Bone Marrow Transplant 1.3.3 Heart Transplant 1.3.4 Kidney Transplant 1.3.5 Liver Transplant 1.3.6 Lung Transplant 1.4 Study Objectives 1.5 Years Considered 2 Market Perspective 2.1 Global Organ Transplant Immunosuppressant Drugs Market Size (2017-2028) 2.1.1 Global Organ Transplant Immunosuppressant Drugs Revenue (2017-2028) 2.1.2 Global Organ Transplant Immunosuppressant Drugs Sales (2017-2028) 2.2 Global Organ Transplant Immunosuppressant Drugs Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028 2.2.1 Global Organ Transplant Immunosuppressant Drugs Sales by Regions (2017-2022) 2.2.2 Global Organ Transplant Immunosuppressant Drugs Revenue by Regions (2017-2022) 2.3 Global Organ Transplant Immunosuppressant Drugs Market Size Forecast by Region 2.3.1 Global Organ Transplant Immunosuppressant Drugs Sales Forecast by Region (2023-2028) 2.3.2 Global Organ Transplant Immunosuppressant Drugs Revenue Forecast by Region (2023-2028) 2.4 Global Top Organ Transplant Immunosuppressant Drugs Regions (Countries) Ranking by Market Size 2.5 Organ Transplant Immunosuppressant Drugs Market Dynamics 2.5.1 Organ Transplant Immunosuppressant Drugs Market Trends 2.5.2 Organ Transplant Immunosuppressant Drugs Market Drivers 2.5.3 Organ Transplant Immunosuppressant Drugs Market Challenges 2.5.4 Organ Transplant Immunosuppressant Drugs Market Restraints 3 Competitive Landscape by Manufacturers 3.1 Global Top Organ Transplant Immunosuppressant Drugs Manufacturers by Sales (2017-2022) 3.1.1 Global Organ Transplant Immunosuppressant Drugs Sales by Manufacturers (2017-2022) 3.1.2 Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global 5 and 10 Largest Manufacturers by Organ Transplant Immunosuppressant Drugs Sales in 2021 3.2 Global Top Manufacturers Organ Transplant Immunosuppressant Drugs by Revenue 3.2.1 Global Organ Transplant Immunosuppressant Drugs Revenue by Manufacturers (2017-2022) 3.2.2 Top Organ Transplant Immunosuppressant Drugs Manufacturers Covered: Ranking by Revenue 3.2.3 Global Organ Transplant Immunosuppressant Drugs Revenue Share by Manufacturers (2017-2022) 3.2.4 Global Organ Transplant Immunosuppressant Drugs Market Concentration Ratio (CR5 and HHI) 3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Organ Transplant Immunosuppressant Drugs as of 2021) 3.4 Global Organ Transplant Immunosuppressant Drugs Average Selling Price (ASP) by Manufacturers 3.5 Key Manufacturers Organ Transplant Immunosuppressant Drugs Plants/Factories Distribution and Area Served 3.6 Date of Key Manufacturers Enter into Organ Transplant Immunosuppressant Drugs Market 3.7 Key Manufacturers Organ Transplant Immunosuppressant Drugs Product Offered 3.8 Mergers & Acquisitions, Expansion Plans 4 Global Organ Transplant Immunosuppressant Drugs Market Size by Type 4.1 Global Organ Transplant Immunosuppressant Drugs Historic Market Review by Type (2017-2022) 4.1.1 Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Type (2017-2022) 4.1.2 Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Type (2017-2022) 4.1.3 Organ Transplant Immunosuppressant Drugs Price by Type (2017-2022) 4.2 Global Organ Transplant Immunosuppressant Drugs Market Estimates and Forecasts by Type (2023-2028) 4.2.1 Global Organ Transplant Immunosuppressant Drugs Sales Forecast by Type (2023-2028) 4.2.2 Global Organ Transplant Immunosuppressant Drugs Revenue Forecast by Type (2023-2028) 4.2.3 Organ Transplant Immunosuppressant Drugs Price Forecast by Type (2023-2028) 5 Global Organ Transplant Immunosuppressant Drugs Market Size by Application 5.1 Global Organ Transplant Immunosuppressant Drugs Historic Market Review by Application (2017-2022) 5.1.1 Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Application (2017-2022) 5.1.2 Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Application (2017-2022) 5.1.3 Organ Transplant Immunosuppressant Drugs Price by Application (2017-2022) 5.2 Global Organ Transplant Immunosuppressant Drugs Market Estimates and Forecasts by Application (2023-2028) 5.2.1 Global Organ Transplant Immunosuppressant Drugs Sales Forecast by Application (2023-2028) 5.2.2 Global Organ Transplant Immunosuppressant Drugs Revenue Forecast by Application (2023-2028) 5.2.3 Organ Transplant Immunosuppressant Drugs Price Forecast by Application (2023-2028) 6 North America 6.1 North America Organ Transplant Immunosuppressant Drugs Sales Breakdown by Company 6.1.1 North America Organ Transplant Immunosuppressant Drugs Sales by Company (2017-2022) 6.1.2 North America Organ Transplant Immunosuppressant Drugs Revenue by Company (2017-2022) 6.2 North America Organ Transplant Immunosuppressant Drugs Market Size by Type 6.2.1 North America Organ Transplant Immunosuppressant Drugs Sales by Type (2017-2028) 6.2.2 North America Organ Transplant Immunosuppressant Drugs Revenue by Type (2017-2028) 6.3 North America Organ Transplant Immunosuppressant Drugs Market Size by Application 6.3.1 North America Organ Transplant Immunosuppressant Drugs Sales by Application (2017-2028) 6.3.2 North America Organ Transplant Immunosuppressant Drugs Revenue by Application (2017-2028) 6.4 North America Organ Transplant Immunosuppressant Drugs Market Size by Country 6.4.1 North America Organ Transplant Immunosuppressant Drugs Sales by Country (2017-2028) 6.4.2 North America Organ Transplant Immunosuppressant Drugs Revenue by Country (2017-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Organ Transplant Immunosuppressant Drugs Sales Breakdown by Company 7.1.1 Europe Organ Transplant Immunosuppressant Drugs Sales by Company (2017-2022) 7.1.2 Europe Organ Transplant Immunosuppressant Drugs Revenue by Company (2017-2022) 7.2 Europe Organ Transplant Immunosuppressant Drugs Market Size by Type 7.2.1 Europe Organ Transplant Immunosuppressant Drugs Sales by Type (2017-2028) 7.2.2 Europe Organ Transplant Immunosuppressant Drugs Revenue by Type (2017-2028) 7.3 Europe Organ Transplant Immunosuppressant Drugs Market Size by Application 7.3.1 Europe Organ Transplant Immunosuppressant Drugs Sales by Application (2017-2028) 7.3.2 Europe Organ Transplant Immunosuppressant Drugs Revenue by Application (2017-2028) 7.4 Europe Organ Transplant Immunosuppressant Drugs Market Size by Country 7.4.1 Europe Organ Transplant Immunosuppressant Drugs Sales by Country (2017-2028) 7.4.2 Europe Organ Transplant Immunosuppressant Drugs Revenue by Country (2017-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 8 Asia Pacific 8.1 Asia Pacific Organ Transplant Immunosuppressant Drugs Sales Breakdown by Company 8.1.1 Asia Pacific Organ Transplant Immunosuppressant Drugs Sales by Company (2017-2022) 8.1.2 Asia Pacific Organ Transplant Immunosuppressant Drugs Revenue by Company (2017-2022) 8.2 Asia Pacific Organ Transplant Immunosuppressant Drugs Market Size by Type 8.2.1 Asia Pacific Organ Transplant Immunosuppressant Drugs Sales by Type (2017-2028) 8.2.2 Asia Pacific Organ Transplant Immunosuppressant Drugs Revenue by Type (2017-2028) 8.3 Asia Pacific Organ Transplant Immunosuppressant Drugs Market Size by Application 8.3.1 Asia Pacific Organ Transplant Immunosuppressant Drugs Sales by Application (2017-2028) 8.3.2 Asia Pacific Organ Transplant Immunosuppressant Drugs Revenue by Application (2017-2028) 8.4 Asia Pacific Organ Transplant Immunosuppressant Drugs Market Size by Region 8.4.1 Asia Pacific Organ Transplant Immunosuppressant Drugs Sales by Region 8.4.2 Asia Pacific Organ Transplant Immunosuppressant Drugs Revenue by Region 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 India 8.4.7 Australia 8.4.8 Taiwan 8.4.9 Indonesia 8.4.10 Thailand 8.4.11 Malaysia 8.4.12 Philippines 8.4.13 Vietnam 9 Latin America 9.1 Latin America Organ Transplant Immunosuppressant Drugs Sales Breakdown by Company 9.1.1 Latin America Organ Transplant Immunosuppressant Drugs Sales by Company (2017-2022) 9.1.2 Latin America Organ Transplant Immunosuppressant Drugs Revenue by Company (2017-2022) 9.2 Latin America Organ Transplant Immunosuppressant Drugs Market Size by Type 9.2.1 Latin America Organ Transplant Immunosuppressant Drugs Sales by Type (2017-2028) 9.2.2 Latin America Organ Transplant Immunosuppressant Drugs Revenue by Type (2017-2028) 9.3 Latin America Organ Transplant Immunosuppressant Drugs Market Size by Application 9.3.1 Latin America Organ Transplant Immunosuppressant Drugs Sales by Application (2017-2028) 9.3.2 Latin America Organ Transplant Immunosuppressant Drugs Revenue by Application (2017-2028) 9.4 Latin America Organ Transplant Immunosuppressant Drugs Market Size by Country 9.4.1 Latin America Organ Transplant Immunosuppressant Drugs Sales by Country (2017-2028) 9.4.2 Latin America Organ Transplant Immunosuppressant Drugs Revenue by Country (2017-2028) 9.4.3 Mexico 9.4.4 Brazil 9.4.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales Breakdown by Company 10.1.1 Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales by Company (2017-2022) 10.1.2 Middle East and Africa Organ Transplant Immunosuppressant Drugs Revenue by Company (2017-2022) 10.2 Middle East and Africa Organ Transplant Immunosuppressant Drugs Market Size by Type 10.2.1 Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales by Type (2017-2028) 10.2.2 Middle East and Africa Organ Transplant Immunosuppressant Drugs Revenue by Type (2017-2028) 10.3 Middle East and Africa Organ Transplant Immunosuppressant Drugs Market Size by Application 10.3.1 Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales by Application (2017-2028) 10.3.2 Middle East and Africa Organ Transplant Immunosuppressant Drugs Revenue by Application (2017-2028) 10.4 Middle East and Africa Organ Transplant Immunosuppressant Drugs Market Size by Country 10.4.1 Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales by Country (2017-2028) 10.4.2 Middle East and Africa Organ Transplant Immunosuppressant Drugs Revenue by Country (2017-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 U.A.E 11 Company Profiles 11.1 Roche 11.1.1 Roche Corporation Information 11.1.2 Roche Overview 11.1.3 Roche Organ Transplant Immunosuppressant Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.1.4 Roche Organ Transplant Immunosuppressant Drugs Products and Services 11.1.5 Roche Organ Transplant Immunosuppressant Drugs SWOT Analysis 11.1.6 Roche Recent Developments 11.2 Sanofi 11.2.1 Sanofi Corporation Information 11.2.2 Sanofi Overview 11.2.3 Sanofi Organ Transplant Immunosuppressant Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.2.4 Sanofi Organ Transplant Immunosuppressant Drugs Products and Services 11.2.5 Sanofi Organ Transplant Immunosuppressant Drugs SWOT Analysis 11.2.6 Sanofi Recent Developments 11.3 Astellas Pharma, Inc. 11.3.1 Astellas Pharma, Inc. Corporation Information 11.3.2 Astellas Pharma, Inc. Overview 11.3.3 Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.3.4 Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Products and Services 11.3.5 Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs SWOT Analysis 11.3.6 Astellas Pharma, Inc. Recent Developments 11.4 GlaxoSmithKline plc 11.4.1 GlaxoSmithKline plc Corporation Information 11.4.2 GlaxoSmithKline plc Overview 11.4.3 GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.4.4 GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Products and Services 11.4.5 GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs SWOT Analysis 11.4.6 GlaxoSmithKline plc Recent Developments 11.5 Novartis AG 11.5.1 Novartis AG Corporation Information 11.5.2 Novartis AG Overview 11.5.3 Novartis AG Organ Transplant Immunosuppressant Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.5.4 Novartis AG Organ Transplant Immunosuppressant Drugs Products and Services 11.5.5 Novartis AG Organ Transplant Immunosuppressant Drugs SWOT Analysis 11.5.6 Novartis AG Recent Developments 11.6 Pfizer, Inc. 11.6.1 Pfizer, Inc. Corporation Information 11.6.2 Pfizer, Inc. Overview 11.6.3 Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.6.4 Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Products and Services 11.6.5 Pfizer, Inc. Organ Transplant Immunosuppressant Drugs SWOT Analysis 11.6.6 Pfizer, Inc. Recent Developments 11.7 Veloxis Pharmaceuticals 11.7.1 Veloxis Pharmaceuticals Corporation Information 11.7.2 Veloxis Pharmaceuticals Overview 11.7.3 Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.7.4 Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Products and Services 11.7.5 Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs SWOT Analysis 11.7.6 Veloxis Pharmaceuticals Recent Developments 12 Value Chain and Sales Channels Analysis 12.1 Organ Transplant Immunosuppressant Drugs Value Chain Analysis 12.2 Organ Transplant Immunosuppressant Drugs Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Organ Transplant Immunosuppressant Drugs Production Mode & Process 12.4 Organ Transplant Immunosuppressant Drugs Sales and Marketing 12.4.1 Organ Transplant Immunosuppressant Drugs Sales Channels 12.4.2 Organ Transplant Immunosuppressant Drugs Distributors 12.5 Organ Transplant Immunosuppressant Drugs Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Global Organ Transplant Immunosuppressant Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of Antibodies Table 3. Major Manufacturers of Antiproliferative Agents Table 4. Major Manufacturers of Calcineurin Inhibitors Table 5. Major Manufacturers of mTOR Inhibitors Table 6. Major Manufacturers of Steroids Table 7. Global Organ Transplant Immunosuppressant Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 8. Global Organ Transplant Immunosuppressant Drugs Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028 Table 9. Global Organ Transplant Immunosuppressant Drugs Sales by Region (2017-2022) & (K Doses) Table 10. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Region (2017-2022) Table 11. Global Organ Transplant Immunosuppressant Drugs Revenue by Region (2017-2022) & (US$ Million) Table 12. Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Region (2017-2022) Table 13. Global Organ Transplant Immunosuppressant Drugs Sales Forecast by Region (2023-2028) & (K Doses) Table 14. Global Organ Transplant Immunosuppressant Drugs Sales Market Share Forecast by Region (2023-2028) Table 15. Global Organ Transplant Immunosuppressant Drugs Revenue Forecast by Region (2023-2028) & (US$ Million) Table 16. Global Organ Transplant Immunosuppressant Drugs Revenue Market Share Forecast by Region (2023-2028) Table 17. Top Organ Transplant Immunosuppressant Drugs Regions (Countries) Ranking by Market Size (US$ Million) in 2021 Table 18. Organ Transplant Immunosuppressant Drugs Market Trends Table 19. Organ Transplant Immunosuppressant Drugs Market Drivers Table 20. Organ Transplant Immunosuppressant Drugs Market Challenges Table 21. Organ Transplant Immunosuppressant Drugs Market Restraints Table 22. Global Organ Transplant Immunosuppressant Drugs Sales by Manufacturers (2017-2022) & (K Doses) Table 23. Global Organ Transplant Immunosuppressant Drugs Sales Share by Manufacturers (2017-2022) Table 24. Global Organ Transplant Immunosuppressant Drugs Revenue by Manufacturers (2017-2022) & (US$ Million) Table 25. Ranking of Global Top Organ Transplant Immunosuppressant Drugs Manufacturers by Revenue (US$ Million) in 2021 Table 26. Organ Transplant Immunosuppressant Drugs Revenue Share by Manufacturers (2017-2022) Table 27. Global Organ Transplant Immunosuppressant Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table 28. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Organ Transplant Immunosuppressant Drugs as of 2021) Table 29. Key Manufacturers Organ Transplant Immunosuppressant Drugs Average Selling Price (ASP) & (2017-2022) & (USD/ Dose) Table 30. Key Manufacturers Organ Transplant Immunosuppressant Drugs Plants/Factories Distribution Table 31. Key Manufacturers Organ Transplant Immunosuppressant Drugs Area Served Table 32. Date of Key Manufacturers Enter into Organ Transplant Immunosuppressant Drugs Market Table 33. Key Manufacturers Organ Transplant Immunosuppressant Drugs Product Type Table 34. Mergers & Acquisitions, Expansion Plans Table 35. Global Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Type (2017-2022) Table 36. Global Organ Transplant Immunosuppressant Drugs Sales Share by Type (2017-2022) Table 37. Global Organ Transplant Immunosuppressant Drugs Revenue (US$ Million) Market Share by Type (2017-2022) Table 38. Global Organ Transplant Immunosuppressant Drugs Price (K Doses) by Type (2017-2022) Table 39. Global Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Type (2023-2028) Table 40. Global Organ Transplant Immunosuppressant Drugs Sales Share by Type (2023-2028) Table 41. Global Organ Transplant Immunosuppressant Drugs Revenue (US$ Million) Market Share by Type (2023-2028) Table 42. Global Organ Transplant Immunosuppressant Drugs Revenue Share by Type (2023-2028) Table 43. Global Organ Transplant Immunosuppressant Drugs Price (K Doses) by Type (2023-2028) Table 44. Global Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Application (2017-2022) Table 45. Global Organ Transplant Immunosuppressant Drugs Sales Share by Application (2017-2022) Table 46. Global Organ Transplant Immunosuppressant Drugs Revenue (US$ Million) Market Share by Application (2017-2022) Table 47. Global Organ Transplant Immunosuppressant Drugs Price (K Doses) by Application (2017-2022) Table 48. Global Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Application (2023-2028) Table 49. Global Organ Transplant Immunosuppressant Drugs Sales Share by Application (2023-2028) Table 50. Global Organ Transplant Immunosuppressant Drugs Revenue (US$ Million) Market Share by Application (2023-2028) Table 51. Global Organ Transplant Immunosuppressant Drugs Revenue Share by Application (2023-2028) Table 52. Global Organ Transplant Immunosuppressant Drugs Price (K Doses) by Application (2023-2028) Table 53. North America Organ Transplant Immunosuppressant Drugs Sales by Company (2017-2022) & (K Doses) Table 54. North America Organ Transplant Immunosuppressant Drugs Sales Market Share by Company (2017-2022) Table 55. North America Organ Transplant Immunosuppressant Drugs Revenue by Company (2017-2022) & (US$ Million) Table 56. North America Organ Transplant Immunosuppressant Drugs Revenue Market Share by Company (2017-2022) Table 57. North America Organ Transplant Immunosuppressant Drugs Sales by Type (2017-2022) & (K Doses) Table 58. North America Organ Transplant Immunosuppressant Drugs Sales by Type (2023-2028) & (K Doses) Table 59. North America Organ Transplant Immunosuppressant Drugs Revenue by Type (2017-2022) & (US$ Million) Table 60. North America Organ Transplant Immunosuppressant Drugs Revenue by Type (2023-2028) & (US$ Million) Table 61. North America Organ Transplant Immunosuppressant Drugs Sales by Application (2017-2022) & (K Doses) Table 62. North America Organ Transplant Immunosuppressant Drugs Sales by Application (2023-2028) & (K Doses) Table 63. North America Organ Transplant Immunosuppressant Drugs Revenue by Application (2017-2022) & (US$ Million) Table 64. North America Organ Transplant Immunosuppressant Drugs Revenue by Application (2023-2028) & (US$ Million) Table 65. North America Organ Transplant Immunosuppressant Drugs Sales by Country (2017-2022) & (K Doses) Table 66. North America Organ Transplant Immunosuppressant Drugs Sales by Country (2023-2028) & (K Doses) Table 67. North America Organ Transplant Immunosuppressant Drugs Revenue by Country (2017-2022) & (US$ Million) Table 68. North America Organ Transplant Immunosuppressant Drugs Revenue by Country (2023-2028) & (US$ Million) Table 69. Europe Organ Transplant Immunosuppressant Drugs Sales by Company (2017-2022) & (K Doses) Table 70. Europe Organ Transplant Immunosuppressant Drugs Sales Market Share by Company (2017-2022) Table 71. Europe Organ Transplant Immunosuppressant Drugs Revenue by Company (2017-2022) & (US$ Million) Table 72. Europe Organ Transplant Immunosuppressant Drugs Revenue Market Share by Company (2017-2022) Table 73. Europe Organ Transplant Immunosuppressant Drugs Sales by Type (2017-2022) & (K Doses) Table 74. Europe Organ Transplant Immunosuppressant Drugs Sales by Type (2023-2028) & (K Doses) Table 75. Europe Organ Transplant Immunosuppressant Drugs Revenue by Type (2017-2022) & (US$ Million) Table 76. Europe Organ Transplant Immunosuppressant Drugs Revenue by Type (2023-2028) & (US$ Million) Table 77. Europe Organ Transplant Immunosuppressant Drugs Sales by Application (2017-2022) & (K Doses) Table 78. Europe Organ Transplant Immunosuppressant Drugs Sales by Application (2023-2028) & (K Doses) Table 79. Europe Organ Transplant Immunosuppressant Drugs Revenue by Application (2017-2022) & (US$ Million) Table 80. Europe Organ Transplant Immunosuppressant Drugs Revenue by Application (2023-2028) & (US$ Million) Table 81. Europe Organ Transplant Immunosuppressant Drugs Sales by Country (2017-2022) & (K Doses) Table 82. Europe Organ Transplant Immunosuppressant Drugs Sales by Country (2023-2028) & (K Doses) Table 83. Europe Organ Transplant Immunosuppressant Drugs Revenue by Country (2017-2022) & (US$ Million) Table 84. Europe Organ Transplant Immunosuppressant Drugs Revenue by Country (2023-2028) & (US$ Million) Table 85. Asia Pacific Organ Transplant Immunosuppressant Drugs Sales by Company (2017-2022) & (K Doses) Table 86. Asia Pacific Organ Transplant Immunosuppressant Drugs Sales Market Share by Company (2017-2022) Table 87. Asia Pacific Organ Transplant Immunosuppressant Drugs Revenue by Company (2017-2022) & (US$ Million) Table 88. Asia Pacific Organ Transplant Immunosuppressant Drugs Revenue Market Share by Company (2017-2022) Table 89. Asia Pacific Organ Transplant Immunosuppressant Drugs Sales by Type (2017-2022) & (K Doses) Table 90. Asia Pacific Organ Transplant Immunosuppressant Drugs Sales by Type (2023-2028) & (K Doses) Table 91. Asia Pacific Organ Transplant Immunosuppressant Drugs Revenue by Type (2017-2022) & (US$ Million) Table 92. Asia Pacific Organ Transplant Immunosuppressant Drugs Revenue by Type (2023-2028) & (US$ Million) Table 93. Asia Pacific Organ Transplant Immunosuppressant Drugs Sales by Application (2017-2022) & (K Doses) Table 94. Asia Pacific Organ Transplant Immunosuppressant Drugs Sales by Application (2023-2028) & (K Doses) Table 95. Asia Pacific Organ Transplant Immunosuppressant Drugs Revenue by Application (2017-2022) & (US$ Million) Table 96. Asia Pacific Organ Transplant Immunosuppressant Drugs Revenue by Application (2023-2028) & (US$ Million) Table 97. Asia Pacific Organ Transplant Immunosuppressant Drugs Sales by Region (2017-2022) & (K Doses) Table 98. Asia Pacific Organ Transplant Immunosuppressant Drugs Sales by Region (2023-2028) & (K Doses) Table 99. Asia Pacific Organ Transplant Immunosuppressant Drugs Revenue by Region (2017-2022) & (US$ Million) Table 100. Asia Pacific Organ Transplant Immunosuppressant Drugs Revenue by Region (2023-2028) & (US$ Million) Table 101. Latin America Organ Transplant Immunosuppressant Drugs Sales by Company (2017-2022) & (K Doses) Table 102. Latin America Organ Transplant Immunosuppressant Drugs Sales Market Share by Company (2017-2022) Table 103. Latin America Organ Transplant Immunosuppressant Drugs Revenue by Company (2017-2022) & (US$ Million) Table 104. Latin America Organ Transplant Immunosuppressant Drugs Revenue Market Share by Company (2017-2022) Table 105. Latin America Organ Transplant Immunosuppressant Drugs Sales by Type (2017-2022) & (K Doses) Table 106. Latin America Organ Transplant Immunosuppressant Drugs Sales by Type (2023-2028) & (K Doses) Table 107. Latin America Organ Transplant Immunosuppressant Drugs Revenue by Type (2017-2022) & (US$ Million) Table 108. Latin America Organ Transplant Immunosuppressant Drugs Revenue by Type (2023-2028) & (US$ Million) Table 109. Latin America Organ Transplant Immunosuppressant Drugs Sales by Application (2017-2022) & (K Doses) Table 110. Latin America Organ Transplant Immunosuppressant Drugs Sales by Application (2023-2028) & (K Doses) Table 111. Latin America Organ Transplant Immunosuppressant Drugs Revenue by Application (2017-2022) & (US$ Million) Table 112. Latin America Organ Transplant Immunosuppressant Drugs Revenue by Application (2023-2028) & (US$ Million) Table 113. Latin America Organ Transplant Immunosuppressant Drugs Sales by Country (2017-2022) & (K Doses) Table 114. Latin America Organ Transplant Immunosuppressant Drugs Sales by Country (2023-2028) & (K Doses) Table 115. Latin America Organ Transplant Immunosuppressant Drugs Revenue by Country (2017-2022) & (US$ Million) Table 116. Latin America Organ Transplant Immunosuppressant Drugs Revenue by Country (2023-2028) & (US$ Million) Table 117. Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales by Company (2017-2022) & (K Doses) Table 118. Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales Market Share by Company (2017-2022) Table 119. Middle East and Africa Organ Transplant Immunosuppressant Drugs Revenue by Company (2017-2022) & (US$ Million) Table 120. Middle East and Africa Organ Transplant Immunosuppressant Drugs Revenue Market Share by Company (2017-2022) Table 121. Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales by Type (2017-2022) & (K Doses) Table 122. Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales by Type (2023-2028) & (K Doses) Table 123. Middle East and Africa Organ Transplant Immunosuppressant Drugs Revenue by Type (2017-2022) & (US$ Million) Table 124. Middle East and Africa Organ Transplant Immunosuppressant Drugs Revenue by Type (2023-2028) & (US$ Million) Table 125. Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales by Application (2017-2022) & (K Doses) Table 126. Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales by Application (2023-2028) & (K Doses) Table 127. Middle East and Africa Organ Transplant Immunosuppressant Drugs Revenue by Application (2017-2022) & (US$ Million) Table 128. Middle East and Africa Organ Transplant Immunosuppressant Drugs Revenue by Application (2023-2028) & (US$ Million) Table 129. Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales by Country (2017-2022) & (K Doses) Table 130. Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales by Country (2023-2028) & (K Doses) Table 131. Middle East and Africa Organ Transplant Immunosuppressant Drugs Revenue by Country (2017-2022) & (US$ Million) Table 132. Middle East and Africa Organ Transplant Immunosuppressant Drugs Revenue by Country (2023-2028) & (US$ Million) Table 133. Roche Corporation Information Table 134. Roche Description and Overview Table 135. Roche Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/ Dose) and Gross Margin (2017-2022) Table 136. Roche Organ Transplant Immunosuppressant Drugs Product and Services Table 137. Roche Organ Transplant Immunosuppressant Drugs SWOT Analysis Table 138. Roche Recent Developments Table 139. Sanofi Corporation Information Table 140. Sanofi Description and Overview Table 141. Sanofi Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/ Dose) and Gross Margin (2017-2022) Table 142. Sanofi Organ Transplant Immunosuppressant Drugs Product and Services Table 143. Sanofi Organ Transplant Immunosuppressant Drugs SWOT Analysis Table 144. Sanofi Recent Developments Table 145. Astellas Pharma, Inc. Corporation Information Table 146. Astellas Pharma, Inc. Description and Overview Table 147. Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/ Dose) and Gross Margin (2017-2022) Table 148. Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Product and Services Table 149. Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs SWOT Analysis Table 150. Astellas Pharma, Inc. Recent Developments Table 151. GlaxoSmithKline plc Corporation Information Table 152. GlaxoSmithKline plc Description and Overview Table 153. GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/ Dose) and Gross Margin (2017-2022) Table 154. GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Product and Services Table 155. GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs SWOT Analysis Table 156. GlaxoSmithKline plc Recent Developments Table 157. Novartis AG Corporation Information Table 158. Novartis AG Description and Overview Table 159. Novartis AG Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/ Dose) and Gross Margin (2017-2022) Table 160. Novartis AG Organ Transplant Immunosuppressant Drugs Product and Services Table 161. Novartis AG Organ Transplant Immunosuppressant Drugs SWOT Analysis Table 162. Novartis AG Recent Developments Table 163. Pfizer, Inc. Corporation Information Table 164. Pfizer, Inc. Description and Overview Table 165. Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/ Dose) and Gross Margin (2017-2022) Table 166. Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Product and Services Table 167. Pfizer, Inc. Organ Transplant Immunosuppressant Drugs SWOT Analysis Table 168. Pfizer, Inc. Recent Developments Table 169. Veloxis Pharmaceuticals Corporation Information Table 170. Veloxis Pharmaceuticals Description and Overview Table 171. Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (US$ Million), Average Selling Price (ASP) (USD/ Dose) and Gross Margin (2017-2022) Table 172. Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Product and Services Table 173. Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs SWOT Analysis Table 174. Veloxis Pharmaceuticals Recent Developments Table 175. Key Raw Materials Lists Table 176. Raw Materials Key Suppliers Lists Table 177. Organ Transplant Immunosuppressant Drugs Distributors List Table 178. Organ Transplant Immunosuppressant Drugs Customers List Table 179. Research Programs/Design for This Report Table 180. Key Data Information from Secondary Sources Table 181. Key Data Information from Primary Sources List of Figures Figure 1. Organ Transplant Immunosuppressant Drugs Product Picture Figure 2. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Type in 2021 & 2028 Figure 3. Antibodies Product Picture Figure 4. Antiproliferative Agents Product Picture Figure 5. Calcineurin Inhibitors Product Picture Figure 6. mTOR Inhibitors Product Picture Figure 7. Steroids Product Picture Figure 8. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Application in 2021 & 2028 Figure 9. Bone Marrow Transplant Use Case Figure 10. Heart Transplant Use Case Figure 11. Kidney Transplant Use Case Figure 12. Liver Transplant Use Case Figure 13. Lung Transplant Use Case Figure 14. Organ Transplant Immunosuppressant Drugs Report Years Considered Figure 15. Global Organ Transplant Immunosuppressant Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 16. Global Organ Transplant Immunosuppressant Drugs Market Size 2017-2028 (US$ Million) Figure 17. Global Organ Transplant Immunosuppressant Drugs Sales (2017-2022) & (K Doses) Figure 18. Global Organ Transplant Immunosuppressant Drugs Market Size Market Share by Region: 2021 VS 2028 Figure 19. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Region (2017-2022) Figure 20. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Region in 2021 Figure 21. Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Region in 2017 VS 2021 Figure 22. Global Organ Transplant Immunosuppressant Drugs Sales Share by Manufacturers in 2021 Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Organ Transplant Immunosuppressant Drugs Sales in 2021 Figure 24. Organ Transplant Immunosuppressant Drugs Revenue Share by Manufacturers in 2021 Figure 25. Organ Transplant Immunosuppressant Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 26. Global Organ Transplant Immunosuppressant Drugs Revenue Share by Type (2017-2022) Figure 27. Global Organ Transplant Immunosuppressant Drugs Revenue Growth Rate by Type in 2017 & 2021 Figure 28. Global Organ Transplant Immunosuppressant Drugs Revenue Share by Application (2017-2022) Figure 29. Global Organ Transplant Immunosuppressant Drugs Revenue Growth Rate by Application in 2017 & 2021 Figure 30. North America Organ Transplant Immunosuppressant Drugs Sales Market Share by Type (2017-2028) Figure 31. North America Organ Transplant Immunosuppressant Drugs Revenue Market Share by Type (2017-2028) Figure 32. North America Organ Transplant Immunosuppressant Drugs Sales Market Share by Application (2017-2028) Figure 33. North America Organ Transplant Immunosuppressant Drugs Revenue Market Share by Application (2017-2028) Figure 34. North America Organ Transplant Immunosuppressant Drugs Sales Share by Country (2017-2028) Figure 35. North America Organ Transplant Immunosuppressant Drugs Revenue Share by Country (2017-2028) Figure 36. U.S. Organ Transplant Immunosuppressant Drugs Revenue (2017-2028) & (US$ Million) Figure 37. Canada Organ Transplant Immunosuppressant Drugs Revenue (2017-2028) & (US$ Million) Figure 38. Europe Organ Transplant Immunosuppressant Drugs Sales Market Share by Type (2017-2028) Figure 39. Europe Organ Transplant Immunosuppressant Drugs Revenue Market Share by Type (2017-2028) Figure 40. Europe Organ Transplant Immunosuppressant Drugs Sales Market Share by Application (2017-2028) Figure 41. Europe Organ Transplant Immunosuppressant Drugs Revenue Market Share by Application (2017-2028) Figure 42. Europe Organ Transplant Immunosuppressant Drugs Sales Share by Country (2017-2028) Figure 43. Europe Organ Transplant Immunosuppressant Drugs Revenue Share by Country (2017-2028) Figure 44. Germany Organ Transplant Immunosuppressant Drugs Revenue (2017-2028) & (US$ Million) Figure 45. France Organ Transplant Immunosuppressant Drugs Revenue (2017-2028) & (US$ Million) Figure 46. U.K. Organ Transplant Immunosuppressant Drugs Revenue (2017-2028) & (US$ Million) Figure 47. Italy Organ Transplant Immunosuppressant Drugs Revenue (2017-2028) & (US$ Million) Figure 48. Russia Organ Transplant Immunosuppressant Drugs Revenue (2017-2028) & (US$ Million) Figure 49. Asia Pacific Organ Transplant Immunosuppressant Drugs Sales Market Share by Type (2017-2028) Figure 50. Asia Pacific Organ Transplant Immunosuppressant Drugs Revenue Market Share by Type (2017-2028) Figure 51. Asia Pacific Organ Transplant Immunosuppressant Drugs Sales Market Share by Application (2017-2028) Figure 52. Asia Pacific Organ Transplant Immunosuppressant Drugs Revenue Market Share by Application (2017-2028) Figure 53. Asia Pacific Organ Transplant Immunosuppressant Drugs Sales Share by Region (2017-2028) Figure 54. Asia Pacific Organ Transplant Immunosuppressant Drugs Revenue Share by Region (2017-2028) Figure 55. China Organ Transplant Immunosuppressant Drugs Revenue (2017-2028) & (US$ Million) Figure 56. Japan Organ Transplant Immunosuppressant Drugs Revenue (2017-2028) & (US$ Million) Figure 57. South Korea Organ Transplant Immunosuppressant Drugs Revenue (2017-2028) & (US$ Million) Figure 58. India Organ Transplant Immunosuppressant Drugs Revenue (2017-2028) & (US$ Million) Figure 59. Australia Organ Transplant Immunosuppressant Drugs Revenue (2017-2028) & (US$ Million) Figure 60. Taiwan Organ Transplant Immunosuppressant Drugs Revenue (2017-2028) & (US$ Million) Figure 61. Indonesia Organ Transplant Immunosuppressant Drugs Revenue (2017-2028) & (US$ Million) Figure 62. Thailand Organ Transplant Immunosuppressant Drugs Revenue (2017-2028) & (US$ Million) Figure 63. Malaysia Organ Transplant Immunosuppressant Drugs Revenue (2017-2028) & (US$ Million) Figure 64. Philippines Organ Transplant Immunosuppressant Drugs Revenue (2017-2028) & (US$ Million) Figure 65. Vietnam Organ Transplant Immunosuppressant Drugs Revenue (2017-2028) & (US$ Million) Figure 66. Latin America Organ Transplant Immunosuppressant Drugs Sales Market Share by Type (2017-2028) Figure 67. Latin America Organ Transplant Immunosuppressant Drugs Revenue Market Share by Type (2017-2028) Figure 68. Latin America Organ Transplant Immunosuppressant Drugs Sales Market Share by Application (2017-2028) Figure 69. Latin America Organ Transplant Immunosuppressant Drugs Revenue Market Share by Application (2017-2028) Figure 70. Latin America Organ Transplant Immunosuppressant Drugs Sales Share by Country (2017-2028) Figure 71. Latin America Organ Transplant Immunosuppressant Drugs Revenue Share by Country (2017-2028) Figure 72. Mexico Organ Transplant Immunosuppressant Drugs Revenue (2017-2028) & (US$ Million) Figure 73. Brazil Organ Transplant Immunosuppressant Drugs Revenue (2017-2028) & (US$ Million) Figure 74. Argentina Organ Transplant Immunosuppressant Drugs Revenue (2017-2028) & (US$ Million) Figure 75. Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales Market Share by Type (2017-2028) Figure 76. Middle East and Africa Organ Transplant Immunosuppressant Drugs Revenue Market Share by Type (2017-2028) Figure 77. Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales Market Share by Application (2017-2028) Figure 78. Middle East and Africa Organ Transplant Immunosuppressant Drugs Revenue Market Share by Application (2017-2028) Figure 79. Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales Share by Country (2017-2028) Figure 80. Middle East and Africa Organ Transplant Immunosuppressant Drugs Revenue Share by Country (2017-2028) Figure 81. Turkey Organ Transplant Immunosuppressant Drugs Revenue (2017-2028) & (US$ Million) Figure 82. Saudi Arabia Organ Transplant Immunosuppressant Drugs Revenue (2017-2028) & (US$ Million) Figure 83. U.A.E Organ Transplant Immunosuppressant Drugs Revenue (2017-2028) & (US$ Million) Figure 84. Organ Transplant Immunosuppressant Drugs Value Chain Figure 85. Organ Transplant Immunosuppressant Drugs Production Process Figure 86. Channels of Distribution Figure 87. Distributors Profiles Figure 88. Bottom-up and Top-down Approaches for This Report Figure 89. Data Triangulation Figure 90. Key Executives Interviewed

Roche Sanofi Astellas Pharma, Inc. GlaxoSmithKline plc Novartis AG Pfizer, Inc. Veloxis Pharmaceuticals